Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Blocking certain brain processes reduces mating behavior in female rats.

5α-reductases increase epitestosterone's effect on androgen receptors.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The compound 4c effectively inhibits the enzyme linked to hair loss.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.